Creative Biolabs' large animal in vivo PK service is designed to seamlessly bridge the gap between initial discovery and advanced development by providing robust, translational pharmacokinetic data. We deliver highly specialized animal modeling, state-of-the-art bioanalysis, and full documentation to support your regulatory submissions. Clients can expect to gain increased confidence in lead candidate selection, reduced experimental variability, and a significantly accelerated timeline for advancing their therapeutic research programs.
Large animal in vivo pharmacokinetics (PK) refers to studies conducted in animals such as dogs, pigs, or non-human primates to assess how a drug behaves within their bodies. These studies are often conducted before human trials to gather data on the absorption, distribution, metabolism, and excretion (ADME) of a drug candidate in a more complex biological system than can be achieved in vitro. Large animal studies can provide valuable insights into the pharmacokinetic profile of a drug, helping researchers optimize dosing regimens and predict how the drug will behave in human subjects. They also serve to identify any potential safety concerns or adverse effects early in the drug development process.
Request a consultation to initiate the formal process.
Fig.1 Large animal models.
Large animal pharmacokinetic studies play a critical role in the preclinical evaluation of drug candidates, informing subsequent human clinical trials and contributing to the development of safe and effective medications. From rationalized turnaround times to different routes of administration, Creative Biolabs helps you design customized in vivo PK schedules and antibody and protein studies. We help you minimize the risk of adverse events as your experiment progresses and maximize the likelihood of success in your drug development program.
| Animal Models We Offer |
Pharmacokinetic Parameters We Determine |
Platform Advantages |
|---|---|---|
|
|
|
Applications of Large Animal Model
Large animal PK studies are often conducted to bridge the gap between initial in vitro (test tube or cell culture) experiments and human clinical trials. This helps researchers understand how the drug behaves in a more complex biological system before moving into human trials.
Large animal PK studies can provide valuable information about the safety profile of a drug, including its potential toxicity and side effects in a more physiologically relevant model. This information is crucial for assessing the risk-benefit ratio of the drug before testing it in humans.
Large animal PK studies help determine important pharmacokinetic parameters such as absorption, distribution, metabolism, and excretion (ADME) of the drug in vivo. Understanding these parameters is essential for optimizing dosing regimens and predicting drug behavior in humans.
Large animal PK studies can also aid in optimizing the formulation of the drug, such as determining the most suitable dosage form (e.g., tablets, injections, or infusions) and formulation components (e.g., excipients) for achieving desired pharmacokinetic properties.
In certain cases, large animal PK studies may be conducted in animal models of specific diseases or conditions to assess the drug's efficacy and pharmacokinetics in a relevant disease context. This can provide insights into how the drug interacts with the diseased physiology and inform clinical trial design.
As a trusted partner, Creative Biolabs provides a one-stop shop for DMPK services to support your antibody and protein development. We offer a full range of large animal PK studies, including canines, non-human primates (NHP), pigs, and rabbits. From bioanalysis to metabolite analysis and identification, tissue distribution, to comprehensive toxicological safety assessment services. Our experts will provide you with insights, design studies, guide experimental progress, and deliver reliable experimental results and data analysis.
To leverage the Creative Biolabs advantage - Get a quote today.
Large animal pharmacokinetic studies involve investigating how drugs are absorbed, distributed, metabolized, and eliminated within the bodies of animals such as dogs, pigs, or non-human primates. These studies are conducted in living organisms to simulate how the drug might behave in humans more closely than in vitro (lab-based) experiments.
Large animal pharmacokinetic (PK) testing is typically conducted during the preclinical development phase of a new drug or therapeutic agent.
Creative Biolabs delivers highly predictive PK profiles using translationally relevant models in a globally accredited and high-quality systems environment. With rapid turnaround times and expertise in specialized dosing, we are your essential partner for de-risking lead candidates and accelerating your path to advanced development. You can always trust Creative Biolabs and deliver your project to us. If you have any needs for in vivo PK, please contact us now.